MedTrace Logo

A Phase-II Study Of TOMUDEX Plus Radiotherapy In Subject With Inoperable or Recurrent Rectal Cancer

NCT00590278 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 49

Last updated 2008-01-25

No results posted yet for this study

Summary

The pilot study is designed to investigate the value of Neo-adjuvant Tomudez in combination with radiotherapy in patients with inoperable or recurrent rectal cancer in terms of response rate and increasing the resectability of initially inoperable rectal cancer.

Conditions

  • Inoperable or Recurrent Rectal Cancer

Interventions

DRUG

Tomudex

PROCEDURE

Radiotherapy

PROCEDURE

Haematology

PROCEDURE

Biochemistry

Sponsors & Collaborators

Principal Investigators

  • Tayfun Hancilar, MD · Okmeydani Hospital Istanbul

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00590278 on ClinicalTrials.gov